445 related articles for article (PubMed ID: 23118287)
21. Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Gottlieb AB; Goel N
J Rheumatol Suppl; 2019 Jun; 95():1-3. PubMed ID: 31154397
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Assessment of the Psoriasis Patient (CAPP): A Report from the GRAPPA 2015 Annual Meeting.
Paek SY; Thompson JM; Qureshi AA; Merola JF; Husni ME
J Rheumatol; 2016 May; 43(5):961-4. PubMed ID: 27134270
[TBL] [Abstract][Full Text] [Related]
23. Prologue: 2010 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Mease PJ; Gladman DD
J Rheumatol; 2012 Feb; 39(2):391-3. PubMed ID: 22298263
[TBL] [Abstract][Full Text] [Related]
24. Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting.
Callis Duffin K; Gottlieb AB
J Rheumatol; 2013 Aug; 40(8):1423-4. PubMed ID: 23908537
[TBL] [Abstract][Full Text] [Related]
25. GRAPPA 2011: proceedings from the ultrasound imaging module.
Kaeley GS; D'Agostino MA; Grassi W; Østergaard M; Olivieri I
J Rheumatol; 2012 Nov; 39(11):2211-3. PubMed ID: 23118290
[TBL] [Abstract][Full Text] [Related]
26. GRAPPA Trainees Symposium 2018: A Report from the GRAPPA 2018 Annual Meeting.
Ford AR; Mascia E; Boehncke WH; Ritchlin CT
J Rheumatol Suppl; 2019 Jun; 95():4-10. PubMed ID: 31154398
[TBL] [Abstract][Full Text] [Related]
27. GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting.
Coates LC; Ritchlin CT
J Rheumatol; 2011 Mar; 38(3):526-9. PubMed ID: 21362780
[TBL] [Abstract][Full Text] [Related]
28. Psoriatic arthritis screening tools.
Qureshi AA; Dominguez P; Duffin KC; Gladman DD; Helliwell P; Mease PJ; Husni ME
J Rheumatol; 2008 Jul; 35(7):1423-5. PubMed ID: 18609737
[TBL] [Abstract][Full Text] [Related]
29. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345
[TBL] [Abstract][Full Text] [Related]
30. GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
Szentpetery A; Johnson MA; Ritchlin CT
J Rheumatol; 2014 Jun; 41(6):1200-5. PubMed ID: 24882852
[TBL] [Abstract][Full Text] [Related]
31. On defining musculoskeletal inflammation: a report from the GRAPPA 2011 annual meeting.
Garg A; Gladman DD; Mease PJ
J Rheumatol; 2012 Nov; 39(11):2214-5. PubMed ID: 23118291
[TBL] [Abstract][Full Text] [Related]
32. Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting.
Merola JF; Gottlieb AB
J Rheumatol; 2017 May; 44(5):691-692. PubMed ID: 28461528
[TBL] [Abstract][Full Text] [Related]
33. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
[TBL] [Abstract][Full Text] [Related]
34. GRAPPA Trainees Symposium 2015: A Report from the GRAPPA 2015 Annual Meeting.
Milliken M; Generali E; Marin J; Ritchlin CT
J Rheumatol; 2016 May; 43(5):952-8. PubMed ID: 27134268
[TBL] [Abstract][Full Text] [Related]
35. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
[TBL] [Abstract][Full Text] [Related]
36. Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
Cauli A; Gladman DD; Mathieu A; Olivieri I; Porru G; Tak PP; Sardu C; Ujfalussy I; Scarpa R; Marchesoni A; Taylor WJ; Spadaro A; Fernàndez-Sueiro JL; Salvarani C; Kalden JR; Lubrano E; Carneiro S; Desiati F; Flynn JA; D'Angelo S; Vacca A; VAN Kuijk AW; Catanoso MG; Gruenke M; Peluso R; Parsons WJ; Ferrara N; Contu P; Helliwell PS; Mease PJ;
J Rheumatol; 2011 May; 38(5):898-903. PubMed ID: 21324965
[TBL] [Abstract][Full Text] [Related]
37. Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol; 2017 May; 44(5):658-660. PubMed ID: 28461520
[TBL] [Abstract][Full Text] [Related]
38. Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists?
Lubrano E; Scrivo R; Cantini F; Marchesoni A; Mathieu A; Olivieri I; Salvarani C; Scarpa R; Spadaro A
Arthritis Care Res (Hoboken); 2012 Mar; 64(3):455-8. PubMed ID: 22076786
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.
Ritchlin CT; Qureshi AA; de Vlam K; Pitzalis C; Helliwell PS; Mease PJ; Gladman DD; Krueger GG; Kavanaugh AF; Fitzgerald O
J Rheumatol; 2010 Feb; 37(2):462-7. PubMed ID: 20147482
[TBL] [Abstract][Full Text] [Related]
40. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
